14May
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar
 
            
    On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: 
Goodwin
        
    
 
    Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/
    Related
         
         
                    
                   On May 21, 2020, the Securities and Exchange Commission (the “SEC”) adopted amendments (the “Amen...
                Read More >
           
         
                    
                   March 31, 2020 is the deadline for retroactively correcting most 403(b) plan document defects that o...
                Read More >
           
         
                    
                   Complex construction projects have many moving parts and numerous stakeholders.  Each project often ...
                Read More >
           
         
                    
                   On June 26, 2019, Judge Denise Cote, of the Southern District of New York, granted a motion to compe...
                Read More >
           
         
                    
                   The U.S. Department of Homeland Security (DHS) has finalized plans to charge employers a $10 registr...
                Read More >
           
         
                    
                   COVID-19: Two Sides of the Same Coin -   Introduction -   Globally, the construction industry is lar...
                Read More >